You are here

  • Home
  • Archive
  • Volume 30, Issue 5
  • Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study

Citation Tools

Article menu

This article has a correction. Please see:

Download PDFPDF
Original research
Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Chase D, Huang HQ, Monk BJ, et al
Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study
International Journal of Gynecologic Cancer 2020;30:596-601.